Financhill
Buy
54

JNJ Quote, Financials, Valuation and Earnings

Last price:
$163.15
Seasonality move :
1.05%
Day range:
$159.80 - $166.12
52-week range:
$140.68 - $169.99
Dividend yield:
3.05%
P/E ratio:
17.62x
P/S ratio:
4.41x
P/B ratio:
5.08x
Volume:
22.1M
Avg. volume:
8.2M
1-year change:
9.12%
Market cap:
$396.5B
Revenue:
$88.8B
EPS (TTM):
$9.35

Earnings Data

Next earnings date for JNJ
Oct 14
2025
Most recent earnings per share
$2.29
Missed by $0.39
(Jul 16/2025)
Consensus Estimate
$2.68
(Jul 16/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JNJ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/14/2025 Q3 $23.8B -- -- $2.76 --
07/16/2025 Q2 $22.9B $23.7B $2.29 $2.68 -$0.39
04/15/2025 Q1 $21.6B $21.9B $4.54 $2.58 $1.96
01/22/2025 Q4 $22.4B $22.5B $1.41 $2.01 -$0.60
10/15/2024 Q3 $22.2B $22.5B $1.11 $2.21 -$1.10
07/17/2024 Q2 $22.3B $22.4B $1.93 $2.70 -$0.77
04/16/2024 Q1 $21.4B $21.4B $1.34 $2.65 -$1.31
01/23/2024 Q4 $21B $21.4B $1.67 $2.28 -$0.61
10/17/2023 Q3 $21B $21.4B $10.21 $2.52 $7.69
07/20/2023 Q2 $24.7B $21.5B $1.96 $2.62 -$0.66
04/18/2023 Q1 -- $20.9B -$0.03 -- --
01/24/2023 Q4 -- $19.9B $1.33 -- --
10/18/2022 Q3 -- $20B $1.68 -- --
07/19/2022 Q2 -- $24B $1.80 -- --
04/19/2022 Q1 -- $23.4B $1.93 -- --
01/25/2022 Q4 -- $9.8B $1.77 -- --
10/19/2021 Q3 -- $23.3B $1.37 -- --
07/21/2021 Q2 -- $23.3B $2.35 -- --
04/20/2021 Q1 -- $22.3B $2.32 -- --
01/26/2021 Q4 -- $22.5B $0.65 -- --
10/13/2020 Q3 -- $21.1B $1.33 -- --
07/16/2020 Q2 -- $18.3B $1.36 -- --
04/14/2020 Q1 -- $20.7B $2.17 -- --
01/22/2020 Q4 -- $20.7B $1.50 -- --
10/15/2019 Q3 -- $20.7B $0.66 -- --
07/16/2019 Q2 -- $20.6B $2.08 -- --
04/16/2019 Q1 -- $20B $1.39 -- --
01/22/2019 Q4 -- $20.4B $1.12 -- --
10/16/2018 Q3 -- $20.3B $1.44 -- --
07/17/2018 Q2 -- $20.8B $1.45 -- --
04/17/2018 Q1 -- $20B $1.60 -- --
01/23/2018 Q4 -- $20.2B -$3.99 -- --
10/17/2017 Q3 -- $19.7B $1.37 -- --
07/18/2017 Q2 -- $18.8B $1.40 -- --
04/18/2017 Q1 -- $17.8B $1.61 -- --
01/24/2017 Q4 -- $18.1B $1.38 -- --
10/18/2016 Q3 -- $17.8B $1.53 -- --
07/19/2016 Q2 -- $18.5B $1.43 -- --
04/19/2016 Q1 -- $17.5B $1.59 -- --
01/26/2016 Q4 -- $17.8B $1.15 -- --
10/13/2015 Q3 -- $17.1B $1.20 -- --

Johnson & Johnson Earnings Questions

  • How Much did Johnson & Johnson Generate in Revenue Last Quarter?

    Johnson & Johnson reported $23.7B worth of top line sales in its most recent quarter.

  • Did Johnson & Johnson Beat Earnings Last Quarter?

    Johnson & Johnson announced earnings per share of $2.29 which represents a miss of analyst forecast a $2.68 per share.

  • Is Johnson & Johnson Profitable?

    Johnson & Johnson reported $16.1B that represents $6.66 per share over the last quarter.

  • What is the Analyst Consensus for Johnson & Johnson EPS Next Year?

    Johnson & Johnson's earnings are forecast to grow from $5.79 per share to $9.95 per share next year representing an increase of 87.74%.

  • When is Johnson & Johnson's Earnings Date?

    Johnson & Johnson's next earnings date is October 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock